Index by author
December 01, 2009; Volume 76,Issue 12
Schade, Andrew
- You have accessAn algorithm for managing warfarin resistanceOlusegun Osinbowale, MD, MBA, RPVI, Monzr Al Malki, MD, Andrew Schade, MD, PhD and John R. Bartholomew, MDCleveland Clinic Journal of Medicine December 2009, 76 (12) 724-730; DOI: https://doi.org/10.3949/ccjm.76a.09062
Some patients need higher-than-expected doses of warfarin to reach their target INR. The cause can be acquired (poor compliance, drug interactions) or hereditary.
Stevens, Tyler
- You have accessAcute pancreatitis: Problems in adherence to guidelinesTyler Stevens, MD, Mansour A. Parsi, MD and R. Matthew Walsh, MDCleveland Clinic Journal of Medicine December 2009, 76 (12) 697-704; DOI: https://doi.org/10.3949/ccjm.76a.09060
Evidence-based guidelines on managing acute pancreatitis are available, but many physicians are not following them.
Walsh, R. Matthew
- You have accessAcute pancreatitis: Problems in adherence to guidelinesTyler Stevens, MD, Mansour A. Parsi, MD and R. Matthew Walsh, MDCleveland Clinic Journal of Medicine December 2009, 76 (12) 697-704; DOI: https://doi.org/10.3949/ccjm.76a.09060
Evidence-based guidelines on managing acute pancreatitis are available, but many physicians are not following them.
Yuzefpolskaya, Melana
- You have accessIs an ACE inhibitor plus an ARB more effective than either drug alone?Franz H. Messerli, MD and Melana Yuzefpolskaya, MDCleveland Clinic Journal of Medicine December 2009, 76 (12) 693-696; DOI: https://doi.org/10.3949/ccjm.76a.09052
No. Dual renin-angiotensin system blockade has never been shown to reduce the rates of morbidity or death from any cause.